Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03332550
Other study ID # LapLav
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 18, 2018
Est. completion date December 31, 2022

Study information

Verified date April 2023
Source Sahlgrenska University Hospital, Sweden
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study is to evaluate clinical results and effect on health and well-being in patients operated for perforated diverticulitis with purulent peritonitis by laparoscopic lavage in Sweden when used outside of prospective studies/trials and in comparison with the traditional treatment, i.e. colon resection with or without stoma formation. A secondary aim is to evaluate the outcome after fecal peritonitis. The hypothesis is that laparoscopic lavage as treatment for perforated diverticulitis with purulent peritonitis is safe, efficient and cost saving, when used in routine health care.


Recruitment information / eligibility

Status Completed
Enrollment 669
Est. completion date December 31, 2022
Est. primary completion date December 31, 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - All patients registered in the Patient registry with ICD 10 codes K57 classified as emergency admissions and with the Nordic Medico-Statistical Committee (NOMESCO) code JAH01(diagnostic laparoscopy), JFB46 (resection of sigmoid colon), JFB60 (resection of sigmoid colon, sigmoidostomy and closure of the distal stump), JFB61 (laparoscopic resection of sigmoid colon, sigmoidostomy and closure of the distal stump), JFB63 (other colon resection, colostomy and closure of the distal stump), JAK04 (laparoscopy and peritoneal lavage), JAW97 (other laparoscopic operation involving abdominal wall, mesentery, peritoneum or the omentum) Exclusion Criteria: - Patients where hospital records reveal that the index admission was misclassified (not perforated diverticulitis) will be excluded. - Patients classified as Hinchey 1-2. - No informed consent received or withdrawal of consent (questionnaire)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Laparoscopic lavage
Operation with laparoscopic lavage for perforated diverticulitis Hinchey 3
Colon resection
Operation with colon resection for perforated diverticulitis Hinchey 4

Locations

Country Name City State
Sweden Sahlgrenska University Hospital Gothenburg Västa Götaland

Sponsors (1)

Lead Sponsor Collaborator
Sahlgrenska University Hospital, Sweden

Country where clinical trial is conducted

Sweden, 

References & Publications (6)

Angenete E, Bock D, Rosenberg J, Haglind E. Laparoscopic lavage is superior to colon resection for perforated purulent diverticulitis-a meta-analysis. Int J Colorectal Dis. 2017 Feb;32(2):163-169. doi: 10.1007/s00384-016-2636-0. Epub 2016 Aug 27. — View Citation

Angenete E, Thornell A, Burcharth J, Pommergaard HC, Skullman S, Bisgaard T, Jess P, Lackberg Z, Matthiessen P, Heath J, Rosenberg J, Haglind E. Laparoscopic Lavage Is Feasible and Safe for the Treatment of Perforated Diverticulitis With Purulent Peritonitis: The First Results From the Randomized Controlled Trial DILALA. Ann Surg. 2016 Jan;263(1):117-22. doi: 10.1097/SLA.0000000000001061. — View Citation

Gehrman J, Angenete E, Bjorholt I, Bock D, Rosenberg J, Haglind E. Health economic analysis of laparoscopic lavage versus Hartmann's procedure for diverticulitis in the randomized DILALA trial. Br J Surg. 2016 Oct;103(11):1539-47. doi: 10.1002/bjs.10230. Epub 2016 Aug 22. — View Citation

Schultz JK, Wallon C, Blecic L, Forsmo HM, Folkesson J, Buchwald P, Korner H, Dahl FA, Oresland T, Yaqub S; SCANDIV Study Group. One-year results of the SCANDIV randomized clinical trial of laparoscopic lavage versus primary resection for acute perforated diverticulitis. Br J Surg. 2017 Sep;104(10):1382-1392. doi: 10.1002/bjs.10567. Epub 2017 Jun 20. — View Citation

Thornell A, Angenete E, Bisgaard T, Bock D, Burcharth J, Heath J, Pommergaard HC, Rosenberg J, Stilling N, Skullman S, Haglind E. Laparoscopic Lavage for Perforated Diverticulitis With Purulent Peritonitis: A Randomized Trial. Ann Intern Med. 2016 Feb 2;164(3):137-45. doi: 10.7326/M15-1210. Epub 2016 Jan 19. — View Citation

Vennix S, Musters GD, Mulder IM, Swank HA, Consten EC, Belgers EH, van Geloven AA, Gerhards MF, Govaert MJ, van Grevenstein WM, Hoofwijk AG, Kruyt PM, Nienhuijs SW, Boermeester MA, Vermeulen J, van Dieren S, Lange JF, Bemelman WA; Ladies trial colloborators. Laparoscopic peritoneal lavage or sigmoidectomy for perforated diverticulitis with purulent peritonitis: a multicentre, parallel-group, randomised, open-label trial. Lancet. 2015 Sep 26;386(10000):1269-1277. doi: 10.1016/S0140-6736(15)61168-0. Epub 2015 Jul 22. Erratum In: Lancet. 2019 Jun 1;393(10187):2200. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Need for further surgical interventions within 12 months of index surgery Number of patients in need of further surgical interventions within 12 months after index surgery. 12 months
Secondary Need for further surgical interventions within 24 months of index surgery Number of patients in need of further surgical interventions within 24 months after index surgery. 24 months
Secondary Colon cancer diagnosis Number of colon cancer diagnosis within 12 months 12 months
Secondary Health economics with regard to the two different treatment modalities. In the analysis data from the study will be combined with prices from the cost-per-patient system at Sveriges Kommuner och Landsting, or where appropriate, from Sahlgrenska University Hospital, in combination with sensitivity testing of results. 2 years
Secondary Percentages of all cases treated by laparoscopic lavage and emergency colon resection, respectively. Percentages of all cases treated by laparoscopic lavage and emergency colon resection, respectively in a national Swedish cohort and in routine health care. 36 months
Secondary Complications (Clavien-Dindo = IIIa) within 90 days of index surgery. Complications (Clavien-Dindo = IIIa) within 90 days of index surgery. 90 days
Secondary Mortality (90 days and 12 months respectively). Mortality (90 days and 12 months respectively). 12 months
Secondary Patient reported outcome after treatment for perforated diverticulitis, function Patient reported outcome as measured using a disease specific questionnaire 2-3 years after index surgery. The questionnaire is developed specifically for this study and will address prevalence, severity and associated distress of symptoms using Likert-type scales regarding function after surgery for perforated diverticulitis. 3 years
Secondary Patient reported outcome after treatment for perforated diverticulitis, quality of life Patient reported outcome using a questionnaire sent out 2-3 years after index surgery for perforated diverticulitis, using EQ-5D for quality of life. 3 years
See also
  Status Clinical Trial Phase
Recruiting NCT04427891 - Characteristics of Abdominal Fluid in Patients With Diverticulitis Hinchey III or IV
Recruiting NCT04220840 - The Damage Control Strategy for the Treatment of Perforated Diverticulitis of the Sigmoid Colon With Diffuse Peritonitis
Recruiting NCT01317485 - Laparoscopic Peritoneal Lavage or Resection for Generalised Peritonitis for Perforated Diverticulitis Phase 3